The future of Anti-viral therapy
MBZM-N-IBT: Promising Broad Spectrum Antiviral for Chikungunya, Herpes, and SARS-COV-2 (Available for Sale or Licensing in Any Country)
Filter by Sector:
Filter by Country:
Sector: MEDICAL, Origin: INDIA
Currently, there are no approved antiviral treatments for Chikungunya virus (CHIKV) or SARS-CoV-2, and resistance to available nucleoside inhibitors poses a growing challenge in treating Herpes Simplex Virus (HSV) infections. This underscores the urgent need for safe and effective broad-spectrum antivirals that can overcome drug resistance and address emerging and re- emerging viral threats.
MBZM-N-IBT is a small-molecule antiviral (molecular weight: 365 g/mol) that shows no acute toxicity (Category 5, OECD-423), making it suitable for long-term use. It functions via a dual mechanism—directly targeting viral proteins and modulating virus-induced inflammation. MBZM-N-IBT has demonstrated efficacy against HSV-1, CHIKV, and SARS-CoV-2, offering a promising broad-spectrum antiviral strategy to bridge current therapeutic gaps.
Key Highlights:
- Potent antiviral properties with high selectivity index (CC50/IC50): >21 (CHIKV), >28 (HSV-1), >30 (SARS-CoV-2)
- Inhibits multiple stages of the viral life cycle
- Directly targets CHIKV and SARS-CoV-2 proteases; targets multiple viral components in HSV-1
- Reduces virus-induced inflammation by suppressing proinflammatory cytokines
- Effective oral dose (15 mg/kg) lowers viral load in infected mice tissues
Patent:
Patent Granted: 347150
Development Stage:
TRL – 4
Seeking:
Available for Sale or Licensing or for Collaboration in any BRICS+. Country
- Expansion to International market through collaboration with Government/Private hospitals
Interested in this opportunity?
Our team will assist you in presenting the offer with management, regular communication & follow-ups, structuring the deal with all possible collaboration options, negotiations and closure of deal. For more details & terms, kindly contact using the above link
Business hours:
Monday – Saturday: 9AM – 6PM
Expand GLOBALLY with B2BricsPlus
Your Trusted Partner for Seamless International Growth and Prosperity
Explore Exciting Opportunities Across BRICS+ Nations
Connect with Strategic Ventures and Unlock New Growth Avenues
Showcase Your Business and Expand Your Global Reach
Join a Thriving Network and Access Global Market Opportunities
Discover the Vision and Mission Behind B2BricsPlus
Connecting Global Businesses for a Sustainable and Prosperous Future